<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> <br />           Distinct Mutations Yeast TAFII25 Differentially Affect                 Composition TFIID SAGA Complexes                     Global Gene Expression Patterns <br />  <br />  <br />              RNA polymerase II transcription factor TFIID, composed TATA-binding protein (TBP)           TBP-associated factors (TAFIIs), nucleates preinitiation complex formation protein-coding gene promoters. <br />           SAGA, second TAFII-containing multiprotein complex, involved transcription regulation Saccharo- <br />           myces cerevisiae. essential protein components common SAGA TFIID yTAFII25. define <br />           minimal evolutionarily conserved 91-amino-acid region TAFII25 containing histone fold domain           necessary sufficient growth vivo. Different temperature-sensitive mutations yTAFII25 chimeras <br />           human homologue TAFII30 arrested cell growth G1 G2/M cell cycle phase displayed <br />           distinct phenotypic changes gene expression patterns. Immunoprecipitation studies revealed TAFII25 <br />           mutation-dependent gene expression phenotypic changes correlated partially integrity           SAGA TFIID. Genome-wide expression analysis revealed TAFII25 temperature-sensitive <br />           mutant alleles individually affect expression 18 33% genes, taken           affect 64% class II genes.  different yTAFII25 mutations induce distinct phenotypes affect           regulation different subsets genes, demonstrating individual TAFII mutant allele reflects           range normal functions. <br />  <br />  <br />    Initiation transcription protein-encoding genes                  cerevisiae SAGA (ySAGA) complex (26), comprises RNA polymerase II (Pol II) requires assembly general                  distinct classes gene products:   Ada proteins <br /> transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF,                    (yAda1, yAda2, yAda3, yGcn5 [yAda4], yAda5 [ySpt20]), TFIIH) promoters form preinitiation complex (31).                isolated genetic screen mutations Preinitiation complex assembly TATA-containing                   relieve toxicity strong VP16 activation domain TATA promoters nucleated transcription fac-                 overexpressed fusion Gal4 DNA-binding domain <br /> tor TFIID, comprises TATA-binding protein (TBP)                    yeast cells (5); (ii) Spt proteins (ySpt3, ySpt7, ySpt8, 14 TBP-associated factors (TAFIIs) (4, 23, 68). <span id='am-6' about='oboInOwl:date' typeof='owl:Thing'>date</span>,                 ySpt20), initially identified suppressors transcription ini- TFIID components Saccharomyces cerevisiae,                  tiation defects caused promoter insertions transpos- <br /> Drosophila, humans identified, partially charac-               able Ty element (16, 17, 22, 65); (iii) subset TBP-associ- <br /> terized, shown conserved evolution                 ated factors (TAFIIs), including TAFII17, TAFII25, TAFII60, <br /> (18, 19, 68).                                                                TAFII68/61, TAFII90 (27); (iv) product    large number recent studies provided direct                   essential gene Tra1 (28, 66), component molecular link histone acetylation transcriptional               Esa1-containing HAT complex NuA4 (1). <br /> activation (reviewed references 11 40).                      addition, similar human multiprotein complexes <br /> shown previously identified coactivators/adapters               characterized, TBP-free TAFII-contain- transcription possess intrinsic histone acetyltransferase                 ing complex (10, 81), PCAF/GCN5 complex (58), (HAT) activity associated large multiprotein com-                  SPT3-TAFII31-GCN5 acetyltransferase complex (48), plexes HATs (71).  1.8- 2-MDa S.                    contain homologues S. cerevisiae GCN5 HAT, <br />                                                                              ADA proteins, SPTs, TAFIIs, human homologue                                                                              yTRA1, TRRAP. <br />   * Corresponding author. Mailing address: Institut G&#195;&#169;n&#195;&#169;tique et             Initial sequence comparisons indicated human TAFII80 Biologie Mol&#195;&#169;culaire et Cellulaire, CNRS/INSERM/ULP, BP 163,              (hTAFII80; homologous Drosophila TAFII60 [dTAFII60] <br /> F-67404 Illkirch Cedex, CU Strasbourg, France. Phone: 33 3 88 65 <br /> 34 44. Fax: 33 388 65 32 01. E-mail: laszlo@igbmc.u-strasbg.fr.              yTAFII60), hTAFII31 (dTAFII40, yTAFII17), hTAFII20 <br />   &#226;&#8364;&#160; Present address: Institut Curie, UMR 218 du CNRS, 75248 Paris            (dTAFII30&#226;&#65533;&#163;, yTAFII61/68) obvious homology histones <br /> Cedex 05, France.                                                            H4, H3, H2B, respectively (33, 38), X-ray crystallog- <br />   &#226;&#8364;&#161; Present address: Wellcome/CRC Institute Department Pa-            raphy showed dTAFII60 dTAFII40 hTAFII28 thology, University Cambridge, Cambridge CB2 1QR, United King- <br /> dom. <br />                                                                              hTAFII18 interact histone fold domains (HFDs) (6, <br />   &#194;&#167; Present address: Friedrich Miescher Institute, CH-4002 Basel,            82). histone fold protein-protein interaction motif <br /> Switzerland.                                                                 originally described heterodimerization core  <br />  <br />                                                                       3178 <br />  VOL. 22, 2002                                          TAF25p MUTATIONS DIFFERENTIALLY AFFECT TRANSCRIPTION                              3179 <br />  <br />  <br />                                                             TABLE 1. Strains <br />  Strain                                                Relevant genotype                                                       Plasmid <br />  <br /> PL3(2n)                       ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3 <br /> DKY12                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       PRS316-TAF25&#226;&#171;&#185; <br /> DKY18                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-&#226;&#338;&#172;C-TAF25 <br /> DKY19                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-&#226;&#338;&#172;N-TAF25 <br /> DKY21                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Chim. 21 <br /> DKY23                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-&#226;&#338;&#172;N-TAF30 <br /> DKY24                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-TAF30&#226;&#171;&#185; <br /> DKY30                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-TAF25&#226;&#171;&#185; <br /> DKY32                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 32 <br /> DKY37                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Chim. 37 <br /> DKY38                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Chim.38 <br /> DKY41                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 41 <br /> DKY42                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 42 <br /> DKY43                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 43 <br /> DKY71                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 71 <br /> DKY72                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 72 <br /> DKY92                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 92 <br /> DKY96                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Chim. 96 <br /> DKY97                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Chim. 97 <br /> DKY98                         MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Chim. 98 <br /> DKY105                        MATa ura3-&#226;&#338;&#172;1 his3&#226;&#338;&#172;-200 leu2-&#226;&#338;&#172;1 trp1::3ERE-URA3        taf25::KanMX2                       YEP10FL-Del. 105 <br />  <br />  <br />  <br />  <br /> tones H4 H3 histones H2A H2B assem-                     Furthermore, genome-wide expression analysis, comparing <br /> bly nucleosome (3, 46). HFD comprises &#226;&#65533;&#163;                single conditionally temperature-sensitive mutations genes <br /> lices linked loops. HFDs histones H3 H2B                 encoding components TFIID SAGA complexes <br /> contain additional &#226;&#65533;&#163;-helix extension N- (&#226;&#65533;&#163;N)                  (29, 34), indicated expression genes requires C-terminal (&#226;&#65533;&#163;C) end, respectively (46).                                    common TAFII subunits, suggesting    vitro transcription assays using different cell-free systems         functions TFIID SAGA widely  cell transfection experiments mammalian cells                quired gene expression (42), contribution suggested TAFIIs essential activation transcrip-           complex remains investigated. subunits <br /> tion response transcriptional activators (13, 25, 35, 50, 63,        shared TFIID SAGA histone fold-containing <br /> 73) important core promoter recognition (12, 49, 64,               TAFIIs, yTAFII90, yTAFII68/61, yTAFII60, yTAFII25, 75).  largest TAFIIs, TAFII250,               yTAFII17, mutants shown affect distinct <br /> shown possess enzymatic activities: kinase activity (14, 57),         gene expression patterns S. cerevisiae. HAT activity (53), ubiquitin-activating/conjugating ac-               date, questions remain concerning role tivity (59).  TAFIIs involved steps          TAFIIs transcription, including TAFIIs required regulation transcription, exact role indi-            small subset promoters. interpretation <br /> vidual contributions unknown.                                          published data complicated fact different <br />    Surprisingly, data experiments carried TAFII                temperature-sensitive alleles single TAFII result <br /> depletion temperature-sensitive TAFII mutants sug-                 broad effects Pol II transcription (39, 67) affect <br /> gested TAFIIs generally required tran-               transcription subset genes (29, 34, 42). Furthermore, <br /> scription activation different yTAFIIs selectively affect         possible separate function TAFII transcription different subsets genes (2, 54, 69, 80).           TFIID SAGA.  TAFII-dependent TAFII-independent promot-                       structure-function study yTAFII25 ers described S. cerevisiae, pro-             S. cerevisiae. define minimal 91-amino-acid region posed following heat shock, TAFII occupancy TAFII-                 yTAFII25 necessary sufficient vegetative growth. <br /> independent promoters increases (41, 44).                     region yTAFII25 contains putative HFD similar TAFIIs essential S. cerevisiae, gene deletions           yTAFIIs (18). HFD yTAFII25 viable (55, 62).                                                   shown mediate selective heterodimerization TFIID- <br />    contrast TAFII class SAGA subunits,              specific components yTAFII47 yTAFII65 SAGA- <br /> subunits, exception Tra1, essential                specific component ySPT7 S. cerevisiae hybrid bac- <br /> growth (72). observation cells containing tempera-              terial coexpression assays (20). <br /> ture-sensitive mutation certain TAFII alleles arrest par-               yTAFII25 required normal cell <br /> ticular points cell cycle support idea         cycle progression different mutations minimal <br /> individual TAFIIs selective effects different subsets           region TAFII25 arrest yeast cell growth different cell cycle <br /> genes required cell cycle regulation. Arrest individual             phases distinct phenotypes, giving evidence mul- <br /> yTAFII90 yTAFII150 mutant strains occurs G2/M                   tiple functions TAFII25. investigate possibility boundary, yTAFII130 mutant strains arrest G1                different phenotypes TAFII25 mutants studied phase cell cycle (2, 79, 80).                                       attributed TFIID- SAGA-specific functions  3180       KIRSCHNER ET AL.                                                                                                                        MOL. CELL. BIOL. <br />  <br />  <br /> TAFII25, examined subunit composition TFIID                             cells/ml, aliquots different dilutions spotted YPD plates SAGA immunoprecipitation tested genome-                                 exposed 28 37&#194;&#176;C. <br />                                                                                           Microscopy. Cells grown described  aliquots taken wide expression pattern TAFII25 mutant strains. results                         given time points, directly cooled ice, washed phosphate-buffered different temperature-sensitive mutations differen-                          saline (PBS), mounted slides. phase contrast fluorescence mi- <br /> tially affect integrity complexes                            croscopy, Leica DMLB microscope used. DAPI (4&#226;&#172;&#732;,6&#226;&#172;&#732;-diamidino-2-phe- <br /> TAFII25 mutant allele influences expression pattern                             nylindole) staining performed concentration 1 &#226;&#65533;&#174;g/ml. <br /> different unique sets genes.  taken                               FACS. Prior fluorescence-activated cell sorting (FACS) analysis, exponen- <br />                                                                                        tially growing cells medium synchronized G2/M phase TAFII25 mutations affect transcription level                          addition nocodazole final concentration 20 &#226;&#65533;&#174;g/ml. G2/M arrest 64% class II genes, similar number genes                              cells monitored microscopically. 90 100% cells arrested <br /> affected combination SAGA TFIID mutants,                                G2/M phase, cells collected centrifugation, washed twice published Lee et al. (42).                                                          ice-cold YPD medium, resuspended warm (37&#194;&#176;C) YPD temperature shift, <br />                                                                                        incubated 37&#194;&#176;C. Aliquots taken exponentially growing <br />                                                                                        cultures (28&#194;&#176;C) synchronization nocodazole 10 min shift 37&#194;&#176;C <br />                          MATERIALS METHODS                                         (t &#226;&#171;&#189; 0) hour 3 h (Fig. 4). <br />    Strains, medium, yeast cell transformation. strains used study         FACS analysis, samples prepared described previously (43) (Table 1) isogenic DKY12 generated strain PL3(2n) (60). S. cerevisiae         incubation time RNase treatment pepsin digestion strains propagated according standard procedures rich medium         doubled. samples analyzed FACScan (Becton Dickinson) <br /> (YPD) appropriate selective medium (SD) tryptophan <span id='am-30' about='obo:IMR_0200234' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-31' property="rdfs:label" content="Uracil" datatype="xsd:string"></span><span id='am-32' property="oboInOwl:id" content="IMR:0200234" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-34' property="oboInOwl:hasDbXref" content="KEGG:C00106" datatype="xsd:string"></span>uracil</span>.           equipped single argon <span id='am-7' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-8' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-11' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="ion" datatype="xsd:string"></span>ion</span> laser. minimum 20,000 cells sample temperature shift experiments, cells grown 28&#194;&#176;C mid-log phase        analyzed using CellQuest software (Becton Dickinson). <br /> (optical density 600 nm [OD600], 0.3 0.5). Prior shifting 37&#194;&#176;C, equal      cell extract preparation, Western blot analysis, antibody produc- <br /> volume warm (46&#194;&#176;C) medium added cultures, cultures          tion. Cultures grown mid-log phase 28&#194;&#176;C shifted 4 h 37&#194;&#176;C transferred 37&#194;&#176;C indicated time. Standard S. cerevisiae genetic manip-      described  cells harvested centrifugation 5 min 3,400 <br /> ulations performed described previously (30). Yeast cell transformation        rpm, washed cold <span id='am-18' about='obo:IMR_0200357' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-19' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-20' property="oboInOwl:hasDbXref" content="KEGG:C00001" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:id" content="IMR:0200357" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="H2O" datatype="xsd:string"></span>H2O</span>, recentrifuged, pellet frozen &#226;&#171;&#186;80&#194;&#176;C carried described previously (24).                                          thawed. volume buffer (40 mM Tris-HCl [pH 7.8], 350 mM NaCl, <br />    Disruption genomic TAFII25 locus. PCR-based homologous recombination             0.1% Tween, 10% glycerol, 1&#226;&#171;&#187; protease inhibitor cocktail [1&#226;&#171;&#187; PIC; 2.5 mg used replace entire coding region allele endogenous           leupeptin, pepstatin, chymostatin, antipain, aprotinin ml]) added <br /> TAFII25 gene strain PL3(2n) kanamycin resistance gene (KanMX2)               pellet, cells broken addition acid-washed glass beads (0.5 <br /> (78). Cells transformed centromeric URA3 plasmid (PRS316) (70)           mm diameter; Sigma). Tubes vortexed vigorously 6 times 20 s harboring wild-type yTAFII25 cDNA. DKY12 strain obtained              1 min cooling ice. cell extracts clarified centrifugation isolated spores selection kanamycin resistance uracil auxotrophy.       30 min 4&#194;&#176;C, protein concentration determined. Protein extracts <br /> proper gene replacement verified Southern blot analysis PCR          stored &#226;&#171;&#186;80&#194;&#176;C. <br /> genomic DNA.                                                                              cell extracts (10 &#226;&#65533;&#174;g) loaded sodium dodecyl sulfate (SDS)&#226;&#8364;&#8220; <br />    Construction truncations deletions yTAFII25 chimeras            10% polyacrylamide gel, separated electrophoresis, electroblotted. tween yTAFII25 hTAFII30. TAFII25 constructs listed Fig. 1              blots treated indicated antibodies, followed incubation generated PCR, digested XhoI BamHI, cloned frame           peroxidase-conjugated goat anti-rabbit immunoglobulin G antibody (Jackson <br /> corresponding sites 2&#226;&#65533;&#174;m expression shuttle vector YEP10-FL (TRP1)               Immuno Research). Chemiluminescence detection performed according (60), containing Flag epitope tag sequence frame N-terminal            manufacturer&#226;&#8364;&#8482;s instructions (Amersham). Specific polyclonal rabbit antibod- <br /> XhoI site. inserts YEP10-FL plasmid expressed control         ies recognizing TFIID- SAGA-specific subunits generated purified phosphoglycerate kinase (PGK) promoter (60). constructs            described previously (22, 67, 68). <br /> verified sequencing. PCR primers used generate different fragments          hybrid assays. L40 S. cerevisiae strain lexA-driven &#226;&#65533;&#164;-galacto- <br /> available request.                                                                sidase reporter gene transformed polyethylene glycol-lithium acetate <br />    Complementation temperature sensitivity tests. determine abilities       method plasmid constructs described text earlier (20, 21). yTAFII25 mutants complement TAFII25 gene, plasmid shuffle              hybrid assay described previously (76). <br /> technique used (8). Strain DKY12 transformed plasmid YEP10FL                 Immunoprecipitation analysis. Immunoprecipitations carried using <br /> containing wild-type mutant alleles TAFII25, transformants        anti-Flag M2&#226;&#8364;&#8220;agarose beads (Sigma) equilibrated buffer  different selected Ura&#226;&#171;&#185; Trp&#226;&#171;&#185; prototrophy. Positive colonies transferred        TAFII25 mutant-containing cell extracts (5 mg) mixed 300 &#226;&#65533;&#174;l 5-fluoro-<span id='am-13' about='obo:IMR_0200265' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-14' property="oboInOwl:id" content="IMR:0200265" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="Orotic acid" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasDbXref" content="KEGG:C00295" datatype="xsd:string"></span>orotic acid</span> plates screen cells lost PRS316-           M2 beads incubated 12 h 4&#194;&#176;C rotation. Beads washed <br /> TAFII25&#226;&#171;&#185; plasmid. Complementing Trp&#226;&#171;&#185; mutants maintained                times 10 volumes buffer times 10 volumes medium URA TRP. temperature sensitivity tests,            buffer B (40 mM Tris-HCl [pH 7.9], 150 mM NaCl, 0.1% Tween, 10% glycerol, <br /> mutants cells grown YPD medium density 0.4 &#226;&#171;&#187; 107 1 &#226;&#171;&#187; 107            1&#226;&#171;&#187; PIC). Bound protein complexes eluted 200 &#226;&#65533;&#174;l buffer B contain- <br />  <br />  <br />  <br />  <br />    FIG. 1. Mapping functional domains yTAFII25.   Schematic representation predicted secondary structure yTAFII25 hTAFII30 proteins. Amino acids important generation different mutants indicated S. cerevisiae   human <br />   proteins. &#226;&#65533;&#163; helices (&#226;&#65533;&#163;) loops (L) histone fold motif shown. (B) Schematic representation different <br /> deletion chimeric mutants yTAFII25 hTAFII30. yTAFII25 derivatives shown grey, nonconserved insertion <br /> indicated hatched box (L2). hTAFII30 sequences indicated black. Chimeric constructs S. cerevisiae human <br /> protein characterized color labeled <span id='am-23' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-24' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-27' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-28' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-29' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span>amino acid</span> positions. complementation assay, carried 28&#194;&#176;C, &#226;&#171;&#185; <br /> indicates ability construct complement lethal &#226;&#338;&#172;taf25 phenotype &#226;&#171;&#186; indicates noncomplementation. Asterisks indicate severity slow-growth phenotype mutants tested 28&#194;&#176;C. Temperature sensitivity (ts) 37&#194;&#176;C indicated &#226;&#171;&#185;. mutant viable elevated temperature, indicated &#226;&#171;&#186;, &#226;&#171;&#185;/&#226;&#171;&#186; indicates slow growth 37&#194;&#176;C. Cell cycle arrest phenotypes indicated arrest G1 G2/M (G2) phase cell cycle. (C) noncomplementing yTAFII25 hTAFII30 mutant proteins <br /> expressed plasmid shuffle. cell extracts indicated strains analyzed Western blotting using anti-Flag monoclonal antibody (lanes 1 4) 4G2 anti-hTAFII30 monoclonal antibody (lanes 5 8), recognizes C-terminal end hTAFII30 (35). (D) complementing yTAFII25 mutants hTAFII30 chimeras overexpressed plasmid shuffle compared yTAFII25 levels wild-type PLa cells (wt). cell extracts indicated strains analyzed Western blot using <br /> polyclonal anti-yTAFII25 antibodies. blot exposed 2 (lanes 1 3) 40 s. facilitate comparison, Del. 32 shown exposures. wild-type yTAFII25, Flag-tagged length yTAFII25, different TAFII25 mutant proteins indicated arrowheads. NS, nonspecific. <br />  VOL. 22, 2002   TAF25p MUTATIONS DIFFERENTIALLY AFFECT TRANSCRIPTION   3181 <br />  3182       KIRSCHNER ET AL.                                                                                                           MOL. CELL. BIOL. <br />  <br /> ing 2.5 mg Flag <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-5' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span>peptide</span> ml 3 h 4&#194;&#176;C. eluates, equal       strain normal 28&#194;&#176;C slightly impaired 37&#194;&#176;C (Fig. <br /> volumes (15 &#226;&#65533;&#174;l) analyzed Western blot.                                        1B, Del. 100).  3-amino-acid deletion (ami- <br />    RNA isolation DNA microarray analysis. RNA isolation, distinct <br /> cultures mutant grown YPD medium 28&#194;&#176;C OD600 0.25. <br />                                                                                       acids 87 89; strain Del. 72) resulted temperature- volume YPD medium 46&#194;&#176;C added bring culture 37&#194;&#176;C.             sensitive phenotype characterized slow growth 28&#194;&#176;C cultures incubated 45 min 37&#194;&#176;C. Following  cultures     nonviability 37&#194;&#176;C (Fig. 1B 2). N- C-terminal immediately cooled, pelleted cooled tubes 5 min 3,400 rpm, washed      deletions able complement TAF25 null phe- cold H2O, repelleted, frozen liquid nitrogen. Total RNA isolated <br />                                                                                       notype (Del. 41 43 Del. 105 Fig. 1B). hot phenol-chloroform method using RNA-Solv reagent (Omega-Blotem) <br /> following manufacturer&#226;&#8364;&#8482;s instructions subsequently quantified. Synthesis          shortest deletion mutant sufficient sup- cDNA biotin-labeled cRNA performed according recommen-              port viability obvious growth defects 28&#194;&#176;C dations Affymetrix  previously published protocols (45). frag-         medium temperature-sensitive phenotype 37&#194;&#176;C  <br /> mented cRNA hybridized Affymetrix oligonucleotide arrays (GeneChip             tains 50% wild-type yTAFII25 protein (Del. 71 <br /> YG-S98). Absolute comparison analyses conducted using Microarray <br /> Suite 4.0 software. total fluorescence intensity array scaled                                                                                       Fig. 1B), e., 91-amino-acid region  amino acids 84 uniform value normalizing average intensity genes (total intensity/   149 180 206) including previously described <br /> number genes) fixed value 1,000.                                           HFD (20). results evolutionarily  <br />    quality total RNA cRNA  fragmentation)             served HFD-containing region (including loop N) yTAFII25 <br /> verified capillary electrophoresis gels. application experi- <br />                                                                                       necessary sufficient viability. <br /> mental arrays, cRNA quality confirmed test chips. Hybridization quality controlled bacterial cRNAs.                                                     attempt dissect HFD determine <br />    Data analysis carried Microarray Suite 4.0 Data Mining Tool       important structural features, yTAFII25 analyzed Bal- <br /> 2.0 Affymetrix,  change mRNA transcription levels detected        (61), program predict local maximum segments  e., gene chips considered significant change twofold    sequence segments conserved relative flanking  comparing mutant strain wild-type strain nonpermis- <br /> sive temperature. twofold cutoff chosen analyzing duplicate <br />                                                                                       gions). short amino acid sequences, PIIPD sample preparation control TAFII25 wild-type strain PL3a 37&#194;&#176;C. Com-         EYGLN motifs (amino acids 86 90 194 198, respec- <br /> paring changes expression independent samples using           tively, yTAFII25), identified Ballast presenting <br /> criteria comparing mutant samples wild-type samples gave 40 genes           highest degree conservation. described  dele- expression twofold (0.63%) 4 genes <br />                                                                                       tion PIIPD motif located loop N region (N-loop) threefold (0.063%)  Fig. 7 represen- <br /> tation average difference change comparison).                                  &#226;&#65533;&#163;N &#226;&#65533;&#163;1 helices HFD important                                                                                       yTAFII25 function (Del. 72 Fig. 1B 2). Deletion                                                                                       EYGLN motif C-terminal &#226;&#65533;&#163;3 helix did affect growth <br />                                   RESULTS <br />                                                                                       conditions tested 28&#194;&#176;C caused temperature <br />    91-amino-acid region yTAFII25 containing putative                         sensitivity 37&#194;&#176;C (Del. 92 Fig. 1B Fig. 2), indicating HFD necessary sufficient vegetative growth S.                           potential role region stability complexes <br /> cerevisiae. Yeast TAFII25 protein encoded single-copy                          . <br /> essential gene (37) containing putative HFD (20)                              length human TAFII30 conserved HFD <br /> Fig. 1A). study structure-function relationship                             substitute yTAFII25 function, partial substitutions <br /> TAFII25, S. cerevisiae &#226;&#338;&#172;taf25 strain complemented                             HFD support viability rise temperature- <br /> yTAFII25 expressed URA/CEN plasmid generated.                              sensitive phenotypes. study functional conservation  <br /> Subsequently plasmid shuffle technique (7) used                            tween S. cerevisiae TAFII25 human homologue hTAFII30, <br /> introduce plasmids expressing different Flag epitope-tagged                           length hTAFII30 conserved HFD tested yTAFII25 wild-type mutant proteins (Fig. 1B). Protein                             complementation TAF25 null strain. length <br /> expression verified (noncomplementing mu-                           hTAFII30 N-terminally truncated version, retains <br /> tants; Fig. 1C) (complementing mutants; Fig. 1D)                         entire HFD (&#226;&#338;&#172;N-hTAFII30), able complement <br /> plasmid shuffle.                                                                      yTAFII25 (Fig. 1B), presence proteins    complementing yTAFII25 derivatives ex-                               easily detectable (Fig. 1C). chimera comprising N-ter- <br /> pressed 2&#226;&#65533;&#174;m plasmid control strong                            minal 73 amino acids S. cerevisiae TAFII25 fused PGK promoter, mutant TAFII25 proteins resulting                           conserved HFD hTAFII30 unable rescue temperature-sensitive phenotype overexpressed com-                          TAF25 null phenotype (Chim. 21, Fig. 1B C). <br /> pared yTAFII25 expression wild-type strain (Fig. 1D).                             despite relatively high amino acid conservation proteins overexpressed 2&#226;&#65533;&#174;m plasmid                             HFD S. cerevisiae human proteins (67% simi- length TAFII25 Del. 32, did result                        larity 43% identity), human protein function- detectable phenotypes (Fig. 1B D). complementation                          ally replace S. cerevisiae counterpart. explained <br /> tests, N-terminal nonconserved 73 amino acids TAFII25                          fact hybrid interaction assays, HFD (&#226;&#338;&#172;N-yTAFII25 Fig. 1B) nonconserved extended                                hTAFII30 interacts yTAFII47 loop 2 (L2) potential HFD  amino acids 149                             yTAFII25 interaction partners, TFIID subunit yTAFII65 180; Del 32. Fig. 1B) (23) deleted                        SAGA component SPT7 (20). <br /> consequence vegetative growth 28&#194;&#176;C (Fig. 2).                                       analyzed chimeric proteins predicted <br />    Interestingly, conserved 10-amino-acid region                            structural motifs conserved minimal yTAFII25-com- <br /> tween amino acids 74 83, encoding putative &#226;&#65533;&#163;N-helix                           plementing region replaced corresponding regions HFD (&#226;&#65533;&#163;N Fig. 2), deleted                              hTAFII30. end, (&#226;&#65533;&#163;N &#226;&#65533;&#163;1) affecting growth (Del. 71 Fig. 1B). 3 amino                         second (&#226;&#65533;&#163;2 &#226;&#65533;&#163;3) &#226;&#65533;&#163;-helices yTAFII25  <br /> acids deleted (amino acids 84 86), growth                         placed corresponding human HFDs (Chim. 37 38  VOL. 22, 2002                                          TAF25p MUTATIONS DIFFERENTIALLY AFFECT TRANSCRIPTION                           3183 <br />  <br />  <br />  <br />  <br />  FIG. 2. yTAFII25 mutants temperature-sensitive phenotypes. indicated strains spotted 10&#226;&#171;&#186;1 serial dilutions YPD <br /> medium tested growth 28&#194;&#176;C (left panel) 37&#194;&#176;C (right panel) comparison strain expressing length yTAFII25. <br />  <br />  <br /> Fig. 1B). fusion protein containing &#226;&#65533;&#163;N &#226;&#65533;&#163;1 helices          cell cycle defects.  morphological changes human protein &#226;&#65533;&#163;2 &#226;&#65533;&#163;3 S. cerevisiae            described TAFII25 temperature-sensitive mutant strains <br /> protein did complement TAF25 null phenotype (Chim. 38              analyzed 28 37&#194;&#176;C light microscopy, Fig. 1B 2), reverse chimera did (Chim.          nuclei visualized using fluorescence microscopy fol- <br /> 37, Fig. 1B C, lane 8). suggests &#226;&#65533;&#163;2 &#226;&#65533;&#163;3           lowing DAPI staining. permissive temperature, helices HFD species-specific function, probably            slight differences strains (Fig. 3). involved interaction specificity, &#226;&#65533;&#163;N &#226;&#65533;&#163;1          example, cells containing Chim. 38 elongated cell <br /> gions interfere essential functions S.          bud morphologies (Fig. 3). nonpermissive temper- <br /> cerevisiae protein normal growth conditions (YPD,                ature (37&#194;&#176;C), temperature-sensitive strains showed <br /> 28&#194;&#176;C). fusion protein Chim. 38 showed,  tem-             abnormal morphologies divided catego- <br /> perature-sensitive phenotype 37&#194;&#176;C (Fig. 1B 2), indicat-         ries:   high proportion cells &#226;&#8364;&#339;mini&#226;&#8364;&#65533; buds <br /> ing &#226;&#65533;&#163;N &#226;&#65533;&#163;1 regions S. cerevisiae protein        aberrant nuclear morphology (Fig. 3, Del. 72 completely interchangeable homologous human               Del. 92) (ii) large cells elongated bud morphol- <br /> sequences involved protein stability           ogies (10 30% cells multiple buds) protein interaction determination  hybrid data          &#226;&#8364;&#339;stained bodies&#226;&#8364;&#65533; cell (Fig. 3, Chim. 38, Chim. 97, .                                                                Del. 98). <br />    dissect region &#226;&#65533;&#163;N &#226;&#65533;&#163;1 helices                                                                           morphological changes typical cell <br /> human protein responsible temperature-sensitive <br />                                                                        cycle defects TAFII temperature-sensitive <br /> phenotype, chimeras                                                                        mutants shown arrest different cell cycle stages  &#226;&#65533;&#163;N helix, N-loop, &#226;&#65533;&#163;1 helix human <br />                                                                        introduction), analyzed DNA content mu- <br /> protein exchanged corresponding regions                                                                        tants FACS. Cells grown 28&#194;&#176;C mid-log phase S. cerevisiae protein (Chim. 96 98 Fig. 1B). Chim. 96, <br />                                                                        synchronized nocodazole, drug blocks cells containing human &#226;&#65533;&#163;N helix, fully complemented                                                                        G2/M phase (2 n). Following synchronization, nocodazole TAF25 null phenotype, good agreement deletion studies (Fig. 1B, compare Chim. 96 Del. 71),              eliminated cells shifted 37&#194;&#176;C 3 h. DNA indicating &#226;&#65533;&#163;N helix contributing        content measured 60 min (Fig. 4). <br /> essential TAFII25 function conditions tested.               Control strains (PL&#226;&#65533;&#163; Del. 32) grew asynchronously  chimeras, containing human              28&#194;&#176;C  55% control strain cells having n 45% <br /> N-loop region (Chim. 97) human &#226;&#65533;&#163;1 helix (Chim. 98),             having 2 n DNA content), nocodazole treatment grew normally 28&#194;&#176;C, albeit somewhat slower wild            cells arrested G2/M phase 2 n DNA content, <br /> type, temperature sensitive 37&#194;&#176;C, Chim. 97            release cells rapidly entered G1 phase 1 n <br /> lesser degree (Fig. 1B 2).                                         DNA content; 3 h 37&#194;&#176;C asynchro- <br />    noted exchange S. cerevisiae       nous (Fig. 4). contrast, Del. 72 Del. 92 strains human sequences Chim. 97 98 reflects             completely arrested nocodazole G2/M phase, 10 amino-acid differences, respectively, compared wild-        30% cells remaining 1 n DNA content G1 <br /> type yTAFII25. results, addition hybrid            phase (Fig. 4). release arrest shift data  strongly suggest N-loop &#226;&#65533;&#163;1 regions         nonpermissive temperature, strains accumulated 1 n <br /> TAFII25 important function-determining regions             DNA content G1 phase. 3 h 37&#194;&#176;C, 95% involved interaction specificity.                                   Del. 72 70% Del. 92 cells accumulated G1 (Fig. <br />    Distinct TAFII25 mutants different morphology              4). <br />  3184     KIRSCHNER ET AL.                                                                                                     MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 3. Changes cell morphology nuclear organization distinct yTAFII25 mutants shift nonpermissive temperature. <br /> Morphological changes yTAFII25 temperature-sensitive mutants visualized phase contrast microscopy (CT). Nuclei visualized fluorescence microscopy DAPI staining. upper lines, S. cerevisiae strains shown 28&#194;&#176;C, lines, <br /> strains shifted 4 h 37&#194;&#176;C. <br />  <br />  <br />  <br />    contrast, Chim. 38 cells, showed higher             fact human TAFII30 does complement TAF25 <br /> proportion cells 2 n DNA content relative              deletion small sequence exchanges S. <br /> trol strains 28&#194;&#176;C  30% cells 1 n 70%            cerevisiae human homologues HFD protein-protein <br /> 2 n DNA content), synchronized efficiently nocoda-              interaction domain caused severe growth defects temper- <br /> zole G2/M phase. release arrest shift            ature-sensitive phenotype (Del. 72, Del. 92, Chim. 38, Chim. nonpermissive temperature Chim. 38 showed slow pro-                 97, Chim. 98 Fig. 1B 2) prompted test gression G1 phase, 70% cells arrested              hybrid assay mutants interact G2/M 3 h 37&#194;&#176;C (Fig. 4). Chim. 98 behaved like Chim.              previously described interaction partners, yTAFII47, <br /> 38, G2/M arrest pronounced (Fig. 4).                yTAFII65, ySPT7 (20). <br />    results confirmed using synchro-                length yTAFII47 yTAFII65 HFD ySPT7 <br /> nization method (&#226;&#65533;&#163;-factor) shifting cells               (amino acids 964 1051) fused VP16 activation <br /> nonpermissive temperature prior synchronization                   domain, length TAFII25 Del. 32, Del. 72, Del. <br /> (data shown). Finally, mutant Chim. 97 did                 92, Chim. 38, Chim. 97, Chim. 98 mutants fused pronounced arrest particular cell cycle phase            LexA DNA-binding domain. LexA DNA-binding domain cell cycle assays performed (Fig. 4 data shown).              fusion proteins tested interaction dif-  TAFII25 mutants classified groups:              ferent VP16 fusions series S. cerevisiae hybrid ex- <br />   Del. 72 Del. 92, arresting G1; (ii) Chim. 38 Chim.         periments 28 37&#194;&#176;C (Fig. 5). Interactions 98, arresting G2/M; (iii) Chim. 97, specific cell        assessed measuring specific &#226;&#65533;&#164;-galactosidase activity S. <br /> cycle arrest stage determined.                                   cerevisiae reporter strain L40, harbors LexA-respon- <br />    data demonstrate S. cerevisiae TAFII25             sive lacZ gene (77). involved proper cell cycle regulation distinct                LexA-TAFII25 presence VP16 does ac- <br /> TAFII25 mutants display different morphology cell cycle               tivate reporter gene (20).  exception defects.  suggest mutations Del. 72                TAFII47, unfused TAFII25 interaction partners, <br /> Del. 92 affect TFIID  TFIID SAGA) function,               TAFII65 SPT7, activated transcription presence known arrest cells G1 phase, Chim. 38               LexA-TAFII25 (data shown). Activation reporter Chim. 98 mutants, arrest G2/M phase,                TAFII47 (coexpressed LexA-TAFII25) low compromise SAGA function  Discussion).                      detectable (870 U specific &#226;&#65533;&#164;-galactosidase activity, com- <br />    Distinct TAFII25 temperature-sensitive mutants display dif-            pared 3,500 U VP16 fusion; Fig. 5, left panel). <br /> ferential interaction profiles interaction partners.           activity TAFII47 result specific <br />  VOL. 22, 2002                                             TAF25p MUTATIONS DIFFERENTIALLY AFFECT TRANSCRIPTION                                3185 <br />  <br />  <br />  <br />  <br />    FIG. 4. Distinct yTAFII25 temperature-sensitive mutants accumulate different cell cycle stages. Cells grown YPD medium 28&#194;&#176;C synchronized nocodazole. nocodazole eliminated, cells shifted 37&#194;&#176;C. Aliquots taken exponentially <br /> growing cultures (28&#194;&#176;C) synchronization nocodazole (Noco.), 10 min shift 37&#194;&#176;C (t &#226;&#171;&#189; 0), hour 3 h. Cells fixed, stained propidium iodide, analyzed FACS. Wild-type Del. 32 used reference strains. Strains carrying Del. <br /> 72 Del. 92 mutations accumulate G1 phase 5 h 37&#194;&#176;C, Del. 38 Del. 98 strains accumulate G2/M phase shift 37&#194;&#176;C. x axis indicates DNA content (1 n 2 n), y axis indicates cell number, axis indicates time. histogram, approximately 20,000 particles gated. <br />  <br />  <br /> recruitment LexA-TAFII25 promoter, does                    wild-type TAFII25. assay, Chim. 92 showed interactions <br /> interfere analysis TAFII25 mutants affecting                 SPT7 TAFII65 (similar wild type) interaction TAFII25 interaction partners.                          reduced level interaction TAFII47. <br />    length TAFII25 Del. 32 (Fig. 1B) showed qualita-                   hybrid interaction results suggest Chim. 98 <br /> tively similar interactions yTAFII47, yTAFII65, ySPT7               specifically, Chim. 38 defect interaction <br /> (Fig. 5). effect temperature shift 37&#194;&#176;C                SPT7 observed phenotypes protein interaction general  exceptions)               proteins partially impaired interaction pronounced. stabilization                protein SAGA complex. contrast, Del. 72, <br /> mutant proteins fusion partners shift ther-            displayed slow-growth phenotype 28&#194;&#176;C, modynamic equilibrium hybrid conditions,                    obvious defect SPT7 interaction completely im- proteins highly overexpressed.  small decrease              paired interaction TAFII65  mutants tested, interaction strength proteins assay              severe reduction interaction TAFII47. <br /> reflect severe functional defect vivo endogenous expres-            results indicate deletions Del. 72 se- <br /> sion levels.  possible qualitatively distin-          verely affect interactions TFIID. Surprisingly, Del. 92 did <br /> guish different mutants capacity interact            apparent reason hybrid assay TAFII25 interaction partners.                                      functional impairment nonpermissive temperature,    Chim. 97 showed interactions comparable wild type                 showed SAGA/TFIID immunoprecipitation experi- TAFII47 SPT7  fourfold decrease                    ments   severe phenotypes interaction TAFII65.  mutants Del. 72, Chim. 38,               nonpermissive temperature. Chim. 98 showed severely impaired interaction                     Taken  hybrid data support idea TAFII47 TAFII65 (Fig. 5). Chim. 38, particularly                HFD TAFII25, N-loop &#226;&#65533;&#163;1 regions nonpermissive temperature, Chim. 98 showed                   important determining interaction specificity diminished interaction ySPT7,                 different observed phenotypes mutants tested mutants interact manner comparable                linked changes interaction domain, resulting dif- <br />  3186      KIRSCHNER ET AL.                                                                                                          MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 5. hybrid assay interaction TAFII25 deletion mutants chimeras TFIID-specific (TAFII47 TAFII65) SAGA-specific (SPT7) interaction partners. indicated TAFII25 mutants expressed LexA DNA-binding domain fusions; TAFII25 <br /> interaction partners (TAFII47, TAFII65, SPT7) expressed VP16 activation domain (VP16-AD) fusions (amino acid positions indicated). reporter gene &#226;&#65533;&#164;-galactosidase LexA-binding sites promoter. results shown specific &#226;&#65533;&#164;-galactosidase <br /> activity. Interactions tested 28 37&#194;&#176;C  4 h incubation). Shown results qualitatively identical experiments; error 20%. LexA-TAFII25 fusion constructs activated reporter presence VP16 <br /> activation domain (20) (data shown). <br />  <br />  <br /> ferential interaction putative partners, affecting dif-            ponents  e., yTAFII90, yTAFII61, yTAFII60, yTAFII47, <br /> ferent complexes.                                                             yTAFII40, yGCN5) present comparable levels, <br />    Distinct TAFII25 mutations differentially affect integrity             indicating  independent expression level TFIID SAGA complexes. test loss                  different TAFII25 mutants, incorporated similarly pairwise interactions observed different TAFII25                  endogenous TFIID SAGA complexes (Fig. 6B). Note mutants respective interaction partners                  experiments, Del. 32 strain better control <br /> hybrid assay influences integrity TFIID SAGA                    temperature-sensitive mutants complexes, analyzed polypeptide composition                   Del. 32 mutant context (Fig. 1B). <br /> complexes different TAFII25 mutant strains.  S.                     Surprisingly, complexes prepared Del. 72 strain, <br /> cerevisiae cell extracts prepared wild-type               28&#194;&#176;C TFIID-specific TAFIIs, yTAFII65 mutant strains grown 28&#194;&#176;C 4 h 37&#194;&#176;C                yTAFII130, missing, shift 37&#194;&#176;C analyzed Western blot presence different                    additional SAGA-specific components (SPT7 ADA2) <br /> TFIID SAGA components (Fig. 6A).                                          lost (Fig. 6B, lanes 3 10). lack yTAFII65 <br />    extracts prepared strains grown 28&#194;&#176;C,               Del. 72-containing complexes good agreement <br /> analyzed TAFIIs SAGA components comparably ex-                       hybrid results.  Del. 72-containing <br /> pressed (Fig. 6A, lanes 1 7).  Del. 72 strain,              complexes contained trace amounts TBP 37&#194;&#176;C (Fig. yTAFII65 level lower strains. Inter-                6B, lane 10). TAFII25-containing complexes prepared <br /> estingly, extracts prepared temperature-                  Del. 92 strain 28&#194;&#176;C, tested subunits <br /> sensitive strains grown nonpermissive temperature,                     present  yTAFII17), 37&#194;&#176;C TFIID SAGA components expressed                       tested TFIID SAGA components missing (Fig. <br /> similar levels (Fig. 6A, lanes 8 14). strains                 6B, lanes 4 11), components altered TAFII expression levels cell extracts                 easily detectable Del. 92 cell extract 37&#194;&#176;C (Fig. 6A, <br /> 37&#194;&#176;C: strain Del. 72, yTAFII65 level lower                   lane 11). indicates loss Del. 92 complexes strains, strain Del. 92,             disintegration SAGA TFIID. detectable yTAFII90 yTAFII65 low levels                        immunopurified complexes prepared Chim. 38, <br /> yTAFII61 yTAFII17.                                                        Chim. 97, Chim. 98 strains 37&#194;&#176;C, tested compo- <br />    different TAFII25 proteins contained Flag                  nents TFIID comparable present Del. <br /> epitope tag N-terminal ends, TAFII25 wild-type                   32 control complexes (Fig. 6B, lanes 12 14).  mutant proteins immunoprecipitated anti-                     Chim. 38-containing complexes clearly lacked SAGA-spe- <br /> Flag antibody cell extracts. presence               cific components SPT7 ADA2 (lane 12), Chim. <br /> TFIID SAGA subunits immunoprecipitations                       98-containing complexes lacked SPT7 (lane 14), agreement <br /> analyzed Western blot (Fig. 6B). different TAFII25                     observed impaired interaction mutant proteins completely depleted cell                  mutants SPT7  Fig. 5). <br /> extracts anti-Flag immunoprecipitation, large excess                 results demonstrate temperature-sensitive antibody used immunoprecipitations (data                    phenotype tested strains (Del. 72 92 Chim. 38, <br /> shown). Importantly, immunopurified TAFII25                        97, 98) 37&#194;&#176;C  Fig. 2) consequence taining complexes, tested TFIID SAGA com-                     general disintegration respective TAFII25-containing <br />  VOL. 22, 2002                                           TAF25p MUTATIONS DIFFERENTIALLY AFFECT TRANSCRIPTION                              3187 <br />  <br />  <br />  <br />  <br />   FIG. 6. Analysis TFIID SAGA complex integrity yTAFII25 wild-type mutant strains.   Immunoblot cell extracts <br /> (WCE) prepared yeast cells grown 28&#194;&#176;C 4-h shift 37&#194;&#176;C. Cultures harvested, cell extracts prepared, 10 <br /> &#226;&#65533;&#174;g respective cell extracts separated SDS-PAGE, blotted, analyzed Western blot indicated antibodies. <br /> (B) cell extracts prepared different strains  indicated) immunoprecipitated (IP) using resin-bound anti-Flag antibody recognizes Flag epitope localized N terminus construct. Peptide-eluted complexes separated SDS-PAGE, blotted, analyzed Western blot indicated antibodies. panels B, panels length TAFII25 different <br /> TAFII25 mutants (indicated arrowheads) revealed anti-Flag antibody. <br />  <br />  <br /> complexes. Instead, studied TAFII25 mutations affect              SAGA subunit expression cell extracts pre- <br /> TAFII25-containing complexes different ways:              pared mutant strains misleading Del. 92 strain 37&#194;&#176;C, corresponding TAFII25 muta-               corresponding multiprotein complexes immunopu- <br /> tion able incorporate TFIID SAGA; (ii)          rified analyze weakened subunit interactions. slow-growing Del. 72 strain, TFIID-specific TAFIIs                   Distinct mutations TAFII25 differentially affect ex- <br /> (yTAFII130 yTAFII65) absent TFIID                 pression class II genes. investigate different <br /> 28&#194;&#176;C, 37&#194;&#176;C additional subunits dissociated              TAFII25 mutants influence Pol II transcription, Affymetrix <br /> corresponding complexes triggering total disintegra-            DNA microarray analysis performed  Materials tion TFIID; (iii) complexes Chim. 38 98 strains           Methods). Total RNA prepared described <br /> lost SAGA-specific subunits 37&#194;&#176;C, TFIID                                                                           temperature-sensitive strains (Del. 72, Del. 92, Chim. 38, <br /> unaffected; (iv) complexes Chim. 97 strain                                                                           Chim. 97, Chim 98) grown 28&#194;&#176;C transferred 45 TFIID SAGA composition similar pre- <br />                                                                           min 37&#194;&#176;C. reference, used wild-type strain PL3a. <br /> pared Del. 32 reference strain, shows                                                                           test reproducibility results determine growth defect.  distinct TAFII25 mutations differen- <br /> tially affect composition corresponding TFIID              cutoff changes gene expression, compared results <br /> SAGA complexes: Del. 72 affect TFIID  28&#194;&#176;C)                independent RNA preparations, carried TFIID SAGA composition  37&#194;&#176;C), Chim. 38                    wild-type strain 37&#194;&#176;C tested Affymetrix DNA mi- 98 affect SAGA composition specifically  37&#194;&#176;C).            croarrays. results obtained indicate high reproduc- results appear good agreement                 ibility (Fig. 7). 0.6% weakly expressed <br /> hybrid interaction assay.                                                 genes changed twofold independent <br />     results, study Natarajan            preparations compared. chose twofold <br /> et al. (56), demonstrate conclusions based yTAFII             cutoff significant changes gene expression  3188      KIRSCHNER ET AL.                                                                                                              MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />   FIG. 7. Evaluation microarray data: average difference scatter graph plot independent sample preparations analyzed Affymetrix GeneChip. x y axes relative hybridization signal intensities genes tested. Higher values correspond stronger <br /> expression.  threefold change lines shown. genes qualified present Affymetrix software sample <br /> preparations included (5,734 6,332; Materials Methods Results). data good reproducibility. weakly expressed genes tend fall  threefold change lines. <br />  <br />  <br />  <br />  <br /> mutant analysis, possibility 0.6% error              ential requirements TFIID SAGA published Lee <br /> Materials Methods).                                                     et al. (42). list contains categories 10 genes: TFIID <br />    total 6,332 Pol II genes systematic locus               dependent, SAGA dependent, TFIID SAGA dependent, included analysis (Table 2). genes, 64%                genes transcription affected SAGA <br /> (4,073 genes)  downregulated                    TFIID double mutant. Surprisingly, 10 genes twofold nonpermissive temperature compared                    category, genes unaffected <br /> wild-type strain. genes include nonredundant af-                  TAFII25 mutants.  mutant Del. <br /> fected genes   downregulated) mutant                     72, genes category (CAM1, WTM2, GNA1, <br /> strains  individual mutant, number af-               MSH6), genes second (PHO84, PHO5, SPL2, <br /> fected genes 1,121 2,110  18 33%              YHB1, YJL012C), genes (AAH1, FAR1, <br /> genes analyzed)  Table 2). Interestingly, different <br /> mutants, genes showed increased expression  <br /> crease transcription, 40 30%, respectively.                                         TABLE 2. Total gene expression analysisa <br />    Surprisingly, 132 genes similarly affected                                   Change,  genes (% 6,332 analyzed) <br /> mutant strains analyzed. 3.2% genes af-                TAFII25 <br />                                                                              mutant          Downregulated         Upregulated         downregulated <br /> fected mutations (4,073 genes) 2.1%                                &#226;&#172;&#381;2-fold              &#226;&#172;&#381;2-fold                  &#226;&#172;&#381;2-fold <br /> genes analyzed (6,332 genes). addition, mutant strains compared pairwise genes commonly                       Del. 72            1,124 (18)            447 (7)               1,571 (25) <br />                                                                             Del. 92              554 (9)             700 (11)              1,254 (20) <br /> creased twofold  overlap limited 11%                  Chim. 38             516 (8)           1,106 (17)              1,622 (26) <br /> 28% 5% 13% comparing group                       Chim. 97             524 (8)           1,586 (25)              2,110 (33) <br /> mutants. upregulated genes, comparable results ob-                 Chim. 98             483 (8)             638 (10)              1,121 (18) <br /> tained. data  based affected global                  Total            1,925 (30)          2,512 (40)              4,073 (64) <br /> gene expression pattern, TAFII25 temperature-sensitive                                                                                                      Affymetrix DNA microarray analysis performed. Total RNA pre- <br /> mutants defined categories.                  pared Del. 72, Del. 92, Chim. 38, Chim. 97, Chim 98 strains grown <br />                                                                             28&#194;&#176;C transferred 45 min 37&#194;&#176;C. reference, used wild-type <br /> given individual TAFII25 mutant affects (directly indirectly)            strain PL3a. Numbers percentages genes affected different TAFII25 specific partially overlapping subset Pol II             mutation nonpermissive temperature compared wild-type strain <br /> genes.                                                                      PL3a indicated. Total reflects nonredundant number genes                                                                              downregulated mutants. Genes considered affected ex- <br />    test mutants SAGA TFIID spec-                  pression level twofold wild-type control. <br /> ificity, compared data list genes showing differ-            error estimated 0.6%. <br />  VOL. 22, 2002                                        TAF25p MUTATIONS DIFFERENTIALLY AFFECT TRANSCRIPTION                        3189 <br />  <br />  <br /> YOR095C, PHO3), genes fourth category            cointegration TFIID- SAGA-specific components <br /> (HEM4 TOM7) downregulated twofold,             (Del. 72 37&#194;&#176;C) unable integrate TFIID suggesting TAFII25 mutant affect SAGA            SAGA complexes (Del. 92 37&#194;&#176;C), cells arrest G1 TFIID activity.                                                 phase, suggesting TFIID function crucial entry    contrast, Chim. 38 Chim. 98 downregulate       S-phase cell cycle. Interestingly, immunopurified <br /> expression gene fourth categories      TFIID SAGA complexes Del. 72 strain exception gene downregulated Chim. 38          similar purified cells grown 28 37&#194;&#176;C;  category), expression genes decreased      Del. 72 cells able grow  extremely slowly) twofold second (PHO84, PHO5, SPL2, YHB1,           28&#194;&#176;C 37&#194;&#176;C (Fig. 2). reason YDL124W), SAGA-specific category, genes         Del. 72-containing complexes, TBP incorporation category (AAH1, FAR1, YOR095C, YOR306C), sug-             seriously impaired 37&#194;&#176;C.  possible weak- <br /> gesting mutants influence gene transcription      ened interactions Del. 72 mutant yTAFII65 <br /> affecting SAGA function TFIID.           Del. 72 mutant yTAFII130 functional sults mutants, Del. 92 Chim. 97,          cells 28&#194;&#176;C, allowing survive, interac- clear compared published lists           tions disrupted biochemical purification genes. data suggest,  different mutations       TAFII130 TAFII65 lost immuno- TAFII shared SAGA TFIID specifically            precipitation. <br /> affect function complex.                       fact strains containing Del. 72 Del. 92 <br />                                                                     mutant proteins arrest G1 stage cell cycle,                         DISCUSSION                                  observation mouse cells,                                                                     alleles vertebrate homologue yeast taf25 gene, <br />    results described study indicate minimal      TAFII30, conditionally disrupted, arrest G1 <br /> 91-amino-acid region containing HFD yTAFII25             phase (51), suggests TAFII25 metazoan homo- <br /> protein necessary sufficient vegetative growth.     logues required (directly indirectly) progression <br /> minimal region shorter, seven amino         G1 phase. <br /> acids yTAFII25 (C-terminal HFD) deleted               hand, yeast cells containing Chim. 38 influencing important HFD-HFD interactions               Chim. 98 mutant TAFII25 proteins, solely tween yTAFII25 yTAFII47 yTAFII25 yTAFII47 (20;           polypeptide composition SAGA complex compro- <br /> unpublished data). distinct temperature-      mised, accumulate G2/M stage. TAFII25 mutants <br /> sensitive mutations (truncations, deletions, multiple point     affect interaction mainly SAGA-specific <br /> mutations) minimal HFD-containing region yTAFII25         HFD-containing interaction partner SPT7 immunopre- result single defined phenotype different   cipitation hybrid experiments.  ada1 null <br /> morphological cell cycle phenotypes surpris-      mutation  SAGA component) results morphologi- <br /> ingly distinct gene expression patterns.                            cal features (large elongated cells elongated buds; <br />    findings agreement recent studies        E. vom Baur, unpublished observation) similar (15, 36, 52, 74), arguing individual temperature-         Chim. 38 Chim. 98 mutants 37&#194;&#176;C (Fig. 3).  <br /> sensitive mutants given TAFII used evaluate       good correlation TAFII25 functions TAFII gene regulation. Depending        mutations compromise SAGA integrity mutations nature temperature-sensitive mutation, result     SAGA-specific components. results sug- different phenotypes reflect different        gest cells impaired TFIID  SAGA) func- <br /> functions protein.  observations      tion, arrest G1 phase cell cycle, effects TAFII mutation function           SAGA-specific functions compromizsed, cells accu- studied biochemical context corre-          mulate G2/M phase cell cycle. <br /> sponding multiprotein complexes. data indicate ef-            Interestingly, deleting &#226;&#65533;&#163;N loop N regions fects complex integrity need determined           HFD strain Del. 72 resulted cells accumulating G1 <br /> characterization SAGA- TFIID-specific functions           phase 37&#194;&#176;C; contrast, replacing &#226;&#65533;&#163;N, loop N, &#226;&#65533;&#163;1 <br /> shared TAFIIs possible using appropriate muta-         regions corresponding human sequences (strain Chim. <br /> tions histone fold domain.                                   38) resulted cells accumulating G2/M phase 37&#194;&#176;C.    Different observed phenotypes tested mutants           compositions TFIID SAGA complexes 37&#194;&#176;C linked changes TFIID SAGA complexes. Compar-           different strains: TAFII25-containing TFIID ison different results obtained yTAFII25 mu-        SAGA complexes strain Del. 72 partially <br /> tants suggests effect mutations corre-      dissociated, Chim. 38 strain, SAGA complex <br /> lated integrity TAFII25-containing complexes.       affected, TFIID (Fig. 6). agreement Strains TAFII25 gene deleted viable         biochemical data, gene expression pattern (37), suggesting TFIID SAGA complexes              mutants differs significantly  .  ob- <br /> functional TAFII25. conceivable         servations temperature-sensitive mutations TAFII25 mutant-containing complexes represent TFIID             generated region yTAFII25 result SAGA complexes sufficient viability 28&#194;&#176;C.          different composition corresponding multiprotein com- <br />    strains mutated yTAFII25 protein able         plexes, different phenotypic changes, different gene ex- <br /> enter TAFII25-containing complexes prevents             pression patterns. <br />  3190     KIRSCHNER ET AL.                                                                                           MOL. CELL. BIOL. <br />  <br />  <br />     fact Chim. 97 temperature-sensi-      yTAFII47 interaction yTAFII47 makes additional  <br /> tive strain protein-protein interactions TAFII25-   tacts proteins TFIID. <br /> containing complexes seriously affected (Fig. 6) sug-         second possibility consistent immunoelectron <br /> gests key interactions TAFII-containing     microscopy data, indicated presence complexes transcription factors promoter DNA        molecules yTAFII47 TFIID particle (C. Leu- impaired, lead observed phenotypic         rent, S. L. Sanders, V. Mallouh, P.  Weil, D. B. Kirschner, L. gene expression changes.                                       Tora, P. Schultz, submitted publication).  <br />    different TAFII25 mutations influence TAFII-         based hybrid data, Del. 92 mutation does com- <br /> TAFII TAFII-SAGA component interactions? observa-           pletely destroy interaction TAFII47 TAFII25 <br /> tions suggest loop N region HFD crucial     37&#194;&#176;C, lack interaction interaction yTAFII25 yTAFII65,           reason failure TAFII25 mutant incorporate <br /> deletion region (mutant Del. 72) disrupts interac-    TFIID complex 37&#194;&#176;C. Del. 92 mutation <br /> tion (Fig. 5)  good agreement, yTAFII65       does obvious reason functional impair- <br /> yTAFII130) lost Del. 72-containing TFIID complex       ment, speculate mutation affect inter- <br /> (Fig. 6B). Interestingly, loop N region present    actions known binding partners, lack S. cerevisiae &#226;&#65533;&#163;1 helix replaced corresponding      result rapid degradation human sequences (mutant Chim. 98), yTAFII25 fails inter-        TAFIIs  TAFII90, TAFII65, TAFII61, TAFII17 act yTAFII65 hybrid assay (Fig. 5),            cell extracts 37&#194;&#176;C; Fig. 6A). <br /> yTAFII65 stays associated Chim. 98-containing TFIID          shown HFD SAGA component <br /> complexes  yTAFII130; Fig. 6B). data           SPT7 interact yTAFII25 human TAFII30, <br /> suggest Chim. 98-containing complexes, addi-         hybrid assays vitro (20). Comparison tional TAFII-TAFII interactions able stabilize weak-    functional complementation experiment (Fig. 1B) ened Chim. 98-yTAFII65 interaction TFIID           hybrid interaction studies (Fig. 5) SAGA/ <br /> loop N region important stabilization effect.       TFIID immunoprecipitation experiment (Fig. 6B) suggests <br /> intact HFD human TAFII30 does interact                 human loop N region does influence TAFII25- <br /> yTAFII65 (20), underlining importance ad-       SPT7 interaction (Chim. 97), human &#226;&#65533;&#163;1 region <br /> ditional TAFII-TAFII interactions mutants.                  does (Chim. 98).  corresponding mutant <br />    Mutants Chim. 38, entire human &#226;&#65533;&#163;N-N-              contains human regions (Chim. 38), results loop-&#226;&#65533;&#163;1 region, Chim. 97, human loop        severe defect hybrid TAFII25-SPT7 interaction <br /> N region  amino acid differences compared S.     parallel disintegration SAGA complex. cerevisiae sequences) remaining S. cerevisiae sequences    contrast, amino acid changes Chim. 38 Chim. 98 <br /> (Fig. 1B), retain 10 40% hybrid interac-       mutants prevent yTAFII47 yTAFII65 associating <br /> tions yTAFII65 unchanged TFIID composi-           corresponding TFIID complexes (Fig. 6B). <br /> tion, suggesting loop N region important           introducing human &#226;&#65533;&#163;N-N-loop-&#226;&#65533;&#163;1 region interaction yTAFII25 yTAFII65.            HFD human &#226;&#65533;&#163;1 region HFD S. <br /> study predicts important interactions TAFII25,               cerevisiae yTAFII25 backbone creates mutants yTAFII65, TAFII130, results obtained Del.      mainly impair SAGA composition function. Importantly, <br /> 72-containing TFIID complex indicate loop N regions       Chim. 38 Chim. 98 mutants arrest G2/M TAFII25 yTAFII65 necessary stable          cell cycle phase, suggesting mutants similar, pos- <br /> association yTAFII130 TFIID. interactions        sibly SAGA-specific functions affected nonpermis- <br /> consistent immunoelectron microscopy data               sive temperature. human &#226;&#65533;&#163;1 region contains amino <br /> showed TAFII25, yTAFII65, TAFII130 present        acid substitutions, future important close proximity lobe yTFIID (9; C.           test amino acids crucial yTAFII25- <br /> Leurent, S. L. Sanders, V. Mallouh, P.  Weil, D. B. Kirsch-      SPT7 interaction. <br /> ner, L. Tora, P. Schultz, submitted publication).          Individual TAFII25 mutants influence different allele-spe- <br /> agreement, interaction hTAFII250, human ho-         cific gene expression patterns. main suggestion fol- <br /> mologue yTAFII130, hTAFII30 reported          lowed observations distinct conditionally <br /> (35).                                                              temperature-sensitive mutations TAFII affect <br />    HFD yTAFII25 human TAFII30          transcription different ways, partially specific effects shown interact physically genetically   TFIID SAGA function. test hypothesis, yTFIID component TAFII47 (20). Interestingly,          genome-wide transcription analysis carried DNA TAFII25 mutants tested completely abolished        microarrays. 2.1% genome af- <br /> interaction yTAFII47 yTAFII25 hybrid        fected way mutants, 64% <br /> assay   weakened interactions          global gene expression affected nonredun-  sevenfold 37&#194;&#176;C [Fig. 5]), presence          dant transcription effects gene caused mutations <br /> yTAFII47 immunopurified complexes affected          added. gene array data, mutant <br /> (Fig. 6B). Del. 72 mutant, showed weakest       TAFII allele analyses (15, 36, 52, 74), argue results ob- <br /> interaction TAFII47, did impair cointegration      tained single temperature-sensitive mutation TAFII47 TFIID complex, suggesting additional         TAFII does necessarily reveal functions interactions able stabilize weakened Del. 72-           protein. <br />  VOL. 22, 2002                                        TAF25p MUTATIONS DIFFERENTIALLY AFFECT TRANSCRIPTION                                          3191 <br />  <br />  <br />    clear yTAFII25 mutants individually did       nucleosome bound DNA showed numerous affect expression genes  18 33%);        histone-DNA contacts little single  sum individual contributions revealed global     contacts influence overall nucleosome structure (47). <br /> role yTAFII25 (64% total genes analyzed).           clear HFD HFD-TAFIIs conceivable testing yTAFII25 mutants,      essential&#226;&#8364;&#8221;usually evolutionary conserved possible combined effect larger          protein, N- C-terminal sequences deleted <br /> portion genome maybe genome.         apparent phenotype.  sequences <br /> respect, interesting recent genome-wide analysis,   play important specific roles particular pro- combined effect single mutations shared           moters, contribute general structural <br /> TFIID SAGA subunits account changes             organization TAFII-containing complexes.   70% genome (42). Unexpectedly,            derstand role HFD-TAFIIs, paramount expression genes affected multiple individ-     importance understand organization dimen- <br /> ual mutations HFD-containing TAFII shared TFIID            sional structure TAFIIs TFIID SAGA. HFD- SAGA.                                                           TAFIIs really form nucleosome-like structure(s),    distinct mutations HFD yTAFII25 differently     important identify mutations  combinations muta- <br /> impair TAFII-TAFII, TAFII-SAGA, TAFII tran-               tions) effectively destroy structure scription interactions   speculate      complex understand real importance tran- <br /> different requirements specific regions TAFII25      scription. <br /> HFD global gene expression. TAFII25 mutants result total disintegration TFIID SAGA                                      ACKNOWLEDGMENTS <br /> complexes  possible exception Del. 92), think <br />                                                                        grateful F. Winston antibodies; C. Waltzinger help differential gene expression patterns observed reflect     flow cytometry studies; R. Martin, C. Gaudon, R. Losson distinct functional defects caused given mutation         advice reagents; U. Kothe help certain stages study; <br /> TFIID SAGA complexes partial complexes               Collet help figure preparations; B. Bell W. play role gene regulation certain promoters.      Mohan critically reading manuscript. thank F.  fact 132 genes tran-       Ruffenach oligonucleotide synthesis. <br />                                                                        D.B.K. supported fellowships European Commu- <br /> scription affected mutants way          nity (Marie Curie) Fondation pour la Recherche M&#195;&#169;dicale <br /> suggests genes ones           (FRM), E.v.B. supported European Community RTN <br /> sensitive changes TAFII25.                                    grant (HPRN-CT-2000-00087). work supported funds <br />    Interestingly, looking expression genes      Institut National la Sant&#195;&#169; et la Recherche M&#195;&#169;dicale,                                                                     CNRS, H&#195;&#180;pital Universitaire Strasbourg, Association pour proposed TFIID, SAGA, TFIID                la Recherche sur le Cancer, FRM, Ligue Nationale contre le <br /> SAGA dependent (42), Del. 72 affected         Cancer, European Community grants HPRN-CT-2000-00087 genes categories, suggesting Del. 72 affect   HPRN-CT-2000-00088, Human Frontier Science Program (RG TFIID- SAGA-specific functions. observation        196/98) L.T., NIH grant GM 52461 P W. good agreement biochemical purification data, <br />                                                                                                        <br /> showing Del. 72-containing complexes TFIID- SAGA-specific subunits lost 37&#194;&#176;C.  Chim.        <br />                                                                       <br /> 38 Chim. 98 mutants did influence expression genes         SAGA-dependent TFIID- TFIID- plus              <br />                                                                   <br /> SAGA-dependent categories, supporting SA-           <br /> GA-specific defect mutants.  possible          create mutations shared TAFIIs affect mainly TFIID     <br />                                                                       <br />  SAGA) SAGA functions. identify SAGA-                <br /> TFIID-specific mutants, necessary combine             <br /> expression profiles biochemical analysis complexes         <br /> involved.                                                             <br />    fact,  TAFII25 mutant (36;           study) shows individual phenotype limited          <br /> congruity mutant argues specific          <br /> role TAFII25  probably HFD-TAFIIs)          <br /> diating specific interactions distinct activators pro-         <br /> moter elements. Instead, observations favor view             histone fold domain TAFIIs play instead           <br /> structural role numerous interactions,           HFD-TAFIIs promoter sequences, activators,              (general) transcription factors, contribute             <br /> transcriptional regulation proposed HFD-TAFII nucleo-        like structure(s). Likewise, great number histone            <br /> mutations generated, giving rise plethora pheno-      <br /> types transcription defects (32). crystal structure           <br /> </body></html>